Grant number: SR1101002 | Funding period: 2018 - 2019
Completed
S Shen, Y Sun, M Matsumoto, WJ Shim, E Sinniah, SB Wilson, T Werner, Z Wu, ST Bradford, J Hudson, MH Little, J Powell, Q Nguyen, NJ Palpant
2021-12-01
Pluripotent stem cells underpin a growing sector that leverages their differentiation potential for research, industry, and clinic..
D Neavin, Q Nguyen, MS Daniszewski, HH Liang, HS Chiu, YK Wee, A Senabouth, SW Lukowski, DE Crombie, GE Lidgerwood, D Hernández, JC Vickers, AL Cook, NJ Palpant, A Pébay, AW Hewitt, JE Powell
Background: The discovery that somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) has provided a foundati..